News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
73,869 Results
Type
Article (1925)
Company Profile (2)
Press Release (71942)
Section
Business (25329)
Career Advice (9)
Deals (4553)
Drug Development (8165)
FDA (1806)
Job Trends (799)
News (37023)
Policy (3561)
Tag
2027 BioCapital Standard (1)
Academia (99)
Accelerated approval (5)
ADA (2)
Allergies (25)
Alliances (8164)
ALS (20)
Alzheimer's disease (193)
Antibody-drug conjugate (ADC) (127)
Approvals (1985)
Artificial intelligence (40)
ASCO (37)
Autoimmune disease (40)
Automation (2)
Bankruptcy (9)
Best Places to Work (584)
BIO (9)
Biologics (1)
Biosimilars (98)
BioSpace Insights (1)
Biotechnology (5)
Bladder cancer (32)
Brain cancer (8)
Breast cancer (65)
Cancer (681)
Cardiovascular disease (26)
Career advice (9)
CAR-T (18)
CDC (2)
CDMO (9)
Celiac Disease (1)
Cell therapy (64)
Cervical cancer (5)
Clinical research (7776)
Collaboration (356)
Commercialization (3)
Compensation (28)
Complete response letters (7)
COVID-19 (200)
CRISPR (1)
C-suite (112)
Cystic fibrosis (8)
Data (909)
Depression (18)
Dermatology (12)
Diabetes (46)
Diagnostics (657)
Digital health (7)
Drug discovery (46)
Drug pricing (1)
Duchenne muscular dystrophy (47)
Earnings (8263)
Events (7664)
Executive appointments (80)
FDA (2362)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (169)
Gene editing (7)
Generative AI (1)
Gene therapy (42)
GLP-1 (83)
Government (246)
Grass and pollen (1)
Guidances (40)
Healthcare (1097)
Hematology (14)
HIV (7)
Huntington's disease (3)
IgA nephropathy (27)
Immunology and inflammation (7)
Immuno-oncology (12)
Indications (30)
Infectious disease (228)
Inflammatory bowel disease (25)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (44)
IPO (1640)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Kidney disease (6)
Layoffs (6)
Legal (953)
Licensing (11)
Liver cancer (22)
Longevity (3)
Lung cancer (129)
Lymphoma (57)
Machine learning (1)
Manufacturing (152)
Marketing (4)
MASH (19)
Medical device (1174)
Medtech (1195)
Mergers & acquisitions (3127)
Metabolic disorders (119)
mRNA (8)
Multiple sclerosis (28)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (371)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (42)
Opinion (2)
Ovarian cancer (35)
Pain (22)
Pancreatic cancer (33)
Parkinson's disease (53)
Partnered (4)
Patents (79)
Patient recruitment (92)
Patient selection (2)
Peanut (2)
People (5221)
Peptides (1)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2095)
Phase 2 (3299)
Phase 3 (2934)
Pipeline (1431)
Policy (1)
Postmarket research (241)
Preclinical (711)
Press Release (2)
Prostate cancer (28)
Radiopharmaceuticals (29)
Rare diseases (94)
Real estate (606)
Regenerative medicine (1)
Regulatory (3114)
Reports (9)
Research institute (97)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (25)
Series A (35)
Series B (25)
Service/supplier (1)
Sickle cell disease (8)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (425)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (14)
Vaccines (48)
Venture capital (7)
Weight loss (18)
Women's health (8)
Date
Last 7 days (54)
Last 30 days (226)
Last 365 days (2826)
2026 (2105)
2025 (2684)
2024 (3255)
2023 (3816)
2022 (7003)
2021 (6371)
2020 (5871)
2019 (3858)
2018 (3011)
2017 (3562)
2016 (3173)
2015 (4029)
2014 (3021)
2013 (2601)
2012 (2775)
2011 (2903)
2010 (2664)
Location
Africa (88)
Alabama (5)
Arizona (14)
Arkansas (1)
Asia (22381)
Australia (2500)
California (871)
Canada (499)
China (557)
Colorado (5)
Connecticut (29)
Delaware (9)
Europe (13567)
Florida (96)
Georgia (18)
Hawaii (1)
Illinois (46)
India (62)
Indiana (29)
Japan (371)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (137)
Massachusetts (693)
Michigan (9)
Minnesota (39)
Missouri (3)
Nebraska (3)
Nevada (13)
New Hampshire (1)
New Jersey (544)
New York (300)
North Carolina (132)
Northern California (375)
Ohio (7)
Oregon (1)
Pennsylvania (160)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (429)
Tennessee (6)
Texas (65)
United States (3344)
Utah (35)
Vermont (1)
Virginia (68)
Washington D.C. (3)
Washington State (64)
Wisconsin (8)
Wyoming (1)
73,869 Results for "neuroderm ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Femcare Ltd Acquires Orion Medical Supplies Ltd in the UK
August 31, 2026
·
2 min read
Press Releases
AVS Bio, an Arlington Capital Partners Portfolio Company, Acquires Biorbyt Ltd.
September 23, 2026
·
5 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company - September 7, 2026
September 7, 2026
·
3 min read
Press Releases
InterCure Ltd. Announces 1-for-5 Reverse Share Split
August 19, 2026
·
5 min read
Press Releases
Visionary Holdings’ Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in China
July 29, 2026
·
4 min read
Press Releases
Faron Pharmaceuticals Ltd: Notice of Half-Year Financial Results 2026
August 19, 2026
·
2 min read
Drug Development
AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24
As AbbVie and NeuroDerm race toward potential U.S. approvals later this year, the companies presented strong data at last week’s American Academy of Neurology 2024 annual meeting for their respective continuous subcutaneous levodopa infusions.
April 22, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
July 7, 2026
·
5 min read
Press Releases
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
September 9, 2026
·
6 min read
Press Releases
Alpha Pro Tech, Ltd. Announces Second Quarter 2026 Financial Results
August 6, 2026
·
16 min read
1 of 7,387
Next
